Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonists
    1.
    发明授权
    Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonists 有权
    同位素富集的嘧啶-5-基乙酸衍生物作为CRTH2拮抗剂

    公开(公告)号:US08541419B2

    公开(公告)日:2013-09-24

    申请号:US13061921

    申请日:2009-09-01

    申请人: Tai Wei Ly

    发明人: Tai Wei Ly

    CPC分类号: C07D239/48

    摘要: Provided herein are 2H- and 13C-enriched compounds of formula (I) or (II); wherein R is as defined herein, and wherein at least one hydrogen atom, in certain embodiments, three or more hydrogen atoms, are deuterium atoms or at least one carbon atom is a carbon-13 atom. Also provided are pharmaceutical compositions and methods using the 2H- and 13C-enriched compounds, useful for treating CRTH2-related diseases or disorders such as, for example, asthma, allergic rhinitis, atopic dermatitis, allergic conjuvatitis, Churg-Strauss syndrome, sinusitis, basophilic leukemia, chronic urticaria or basophilic leukocytosis.

    摘要翻译: 本文提供了式(I)或(II)的富含2H-和13C的化合物; 其中R如本文所定义,并且其中至少一个氢原子(在某些实施方案中为三个或更多个氢原子)为氘原子或至少一个碳原子为碳-13原子。 还提供了使用富含2H和13C的化合物的药物组合物和方法,其可用于治疗CRTH2相关疾病或病症,例如哮喘,过敏性鼻炎,特应性皮炎,过敏性结膜炎,Churg-Strauss综合征,鼻窦炎, 嗜碱性白血病,慢性荨麻疹或嗜碱性白细胞增多症。

    Amine salts of a CRTH2 antagonist
    2.
    发明授权
    Amine salts of a CRTH2 antagonist 有权
    CRTH2拮抗剂的胺盐

    公开(公告)号:US08278310B2

    公开(公告)日:2012-10-02

    申请号:US12665705

    申请日:2008-06-18

    申请人: Tai Wei Ly

    发明人: Tai Wei Ly

    CPC分类号: C07D239/48

    摘要: Provided are amine salts of {4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl}-acetic acid, processes for their preparation, pharmaceutical compositions containing them, and their use for treating, preventing, or ameliorating one or more symptoms of a CRTH2-mediated disorder or disease.

    摘要翻译: 提供{4,6-双(二甲基氨基)-2-(4-(4-(三氟甲基)苯甲酰氨基)苄基)嘧啶-5-基} - 乙酸的胺盐,其制备方法,含有它们的药物组合物, 以及它们用于治疗,预防或改善CRTH2介导的病症或疾病的一种或多种症状的用途。